FREEMAN KEVIN D 4
4 · GALECTIN THERAPEUTICS INC · Filed Jul 18, 2025
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2025-07-17$2.90/sh+5,000$14,495→ 49,769 total
Holdings
- 80,000(indirect: By LLC)
Common Stock
- 18,063(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.